Use of quality indicators in neuroblastoma treatment: A feasibility assessment.
Suzan DijkstraKathelijne C J M KraalGodelieve A M TytgatMax M Van NoeselMarc H W A WijnenPeter M HoogerbruggePublished in: Pediatric blood & cancer (2020)
Assessment of QIs in neuroblastoma treatment is feasible. Seven new QIs were found to be feasible to measure and showed improvement over time for three indicators. Monitoring of these QIs during treatment may provide tools for quality improvement activities and comparisons of treatment quality over time or between centers. Further study is required to investigate their association with long-term outcomes.
Keyphrases